#MathOnco
LightNews LightNews
mathcancer.bsky.social
Looking forward to building the next chapter at @michiganstateu.bsky.social! More on this in the coming week!

10/10

#academia #DeanLife #DigitalTwins #mathonco #mathbio #OpenSource #PhysiCell
November 1, 2026 at 5:06 PM
mathcancer.bsky.social
Friday was my last day at IU Luddy School of Informatics, Computing, and Engineering.

I'm so grateful for the opportunities I had to build and grow here in the past ten years. 1/10

#academia #DeanLife #DigitalTwins #mathonco #mathbio #OpenSource #PhysiCell 🧪
November 1, 2026 at 5:06 PM
parmvir.com
You can learn about this year's and past #MoffittIMO workshops here:
imoworkshop.org

#MathOnco #MathBio #DigitalTwins
November 2, 2026 at 3:51 PM
parmvir.com
This convo w/ @cosmicarturo.bsky.social is definitely more philosophical than your usual #BiologyInNumbers fare, but I think it makes it all the more worthwhile.
Links to the full episode here: smb.org/news/13742866
#MathBio #MathOnco #complexity #Scicomm #SciencePodcast
@smbmathbiology.bsky.social
October 23, 2026 at 8:08 PM
parmvir.com
Spying on #Moffitt teams and stealing their cookies 🍪
Will sell team secrets to the highest bidder.

🧪 #MathOnco
November 2, 2026 at 7:37 PM
parmvir.com
Check out @cassyni.bsky.social talk: Cells, bureaucracy and corruption presented by Frederick R Adler
📅 Wednesday 23rd Sep 2026
⏰ 13.00 PM (EDT)
It's not to late to RSVP. Looking forward to seeing you then!

@smbmathbiology.bsky.social #MathBio #MathOnco
September 21, 2026 at 9:03 PM
robjohnnoble.bsky.social
The #mathonco newsletter is effectively a pseudo journal that curates a list of notable preprints and papers (omitting the journal names). Perhaps such newsletters will replace journals. mathematical-oncology.org/newsletter/
Newsletter - Mathematical Oncology
The Mathematical Oncology Community Resource
mathematical-oncology.org
September 21, 2026 at 10:36 AM
glorenzogz.bsky.social
Optimising your 2027 conference itinerary? If digital twins, radiotherapy & #mathonco feature in your objective function, consider PRISM in Milan 🇮🇹

📅 18–21 Jan 2027, Politecnico di Milano
✅ Registration is FREE
⏳ Deadline: 30 Sept 2026
🔗 www.mate.polimi.it/events/PRISM/
September 10, 2026 at 11:19 PM
glorenzogz.bsky.social
🎉 New #mathonco paper out! We developed an MRI-informed poromechanical model to predict glioma growth, representing the brain as a deformable porous material where tumor cells, healthy tissue & interstitial fluid interact. Check it out ! 👇🔗
www.sciencedirect.com/science/arti...
An MRI-informed poromechanical model for organ-scale prediction of glioma growth
Gliomas constitute one of the most aggressive and heterogeneous forms of brain tumors, posing major challenges for understanding their biology and dev…
www.sciencedirect.com
August 28, 2026 at 7:34 PM
mathcancer.bsky.social
The article has great insights from @erlundberg.bsky.social, @yusufroohani.bsky.social, @fabiantheis.bsky.social, @mariabrbic.bsky.social, and many others! (2/4)

#mathonco #mathbio #MultiCellularSystems
August 10, 2026 at 2:16 PM
stroblmar.bsky.social
Attention #MathOnco friends! We'd like to put together a collage of pictures of the mathonco presence at #AACR25 for the #MathOnco newsletter. DM me yours by Monday (05/05) to see yours included.
May 2, 2025 at 2:42 PM
david.fediscience.org.ap.brid.gy
The latest from @smbmathbiology.bsky.social #biologyinnumbers: @math.onco's own Ranjini Bhattacharya, working with Joel Brown to study the role of #tumor cell-cell interactions in the context of #metabolism with #theoreticalbiology #MathOnco […]
Original post on fediscience.org
fediscience.org
January 28, 2026 at 1:51 PM
david.fediscience.org.ap.brid.gy
Well, this is going on next week, the #mathonco25 #MathOnco conference in Tampa, FL

https://mathematical-oncology.org/mathonco25#agenda
October 23, 2025 at 2:28 PM
david.fediscience.org.ap.brid.gy
Moffitt's #csbc center represented by @sandy where he talks about #MathOnco models driving phase i trials to accelerate and enhance how clinical trials are done
October 21, 2025 at 7:24 PM
david.fediscience.org.ap.brid.gy
A #MathOnco conference in beautiful St Pete Beach, FL in the Tampa Bay Area you say? in late October when the weather will be wonderful you say? organized by @sandy and the folks at @math.onco you say?

https://mathematical-oncology.org/mathonco25
Mathematical Oncology Conference - MathOnco25
mathematical-oncology.org
August 2, 2025 at 8:54 PM
david.fediscience.org.ap.brid.gy
Final #MathOnco keynote at #smb2025 @smbmathbiology.bsky.social with Mohit K. Jolly taling about Epithelial to Messenchymal Plasticity (EMP). Great talk and of great importance not just for #Metastasis (the context in which it is usually studied) but also #TreatmentResistance
Mohit Title slide Metastasis:responsible for most of cancer deaths
July 18, 2025 at 5:14 PM
david.fediscience.org.ap.brid.gy
Riley Manning (now at @math.onco) showing her work at University of Minnesota modeling tumor-immune interactions in glioblastoma and how computational models #MathOnco can help us explore how different aspects of these interactions can explain different […]

[Original post on fediscience.org]
Riley Title slide
July 17, 2025 at 11:28 PM
david.fediscience.org.ap.brid.gy
Excellent minisymposium at #smb2025 @smbmathbiology.bsky.social on using imaging to parameterize agent-based models in #MathOnco. One of the speakers my colleague Kasia Rejniak describing a powerful approach to use histology in modeling #Immunotherapy
July 16, 2025 at 8:38 PM
david.fediscience.org.ap.brid.gy
Yesterday's @smbmathbiology.bsky.social #MathOnco minisymp with
@math.onco 's chair and friend @sandy presenting models that capture patient data and help us to understand how to improve treatment schedules in a clinically translatable way #smb2025
Sandy Sandy and a slide
July 15, 2025 at 3:17 PM
david.fediscience.org.ap.brid.gy
I got interviewed in the #MathOnco #youtube channel from Thomas Hillen but instead of linking to it I will share the link to the whole channel since there are so many of them and I don't think I am the best interviewee Thomas had: https://www.youtube.com/@MathOncologyInterviews/videos
March 28, 2025 at 10:14 AM
david.fediscience.org.ap.brid.gy
Excellent seminar at Moffitt's @mathonco by Gustavo França (working with Itai Yanay ) to explain how cell state and plasticity can explain the emergence of resistance in cancer. Experimental data only but would make for an excellent #MathOnco collab
Genetic driven resistance vs plasticity driven resistance title slide Gustavo França
December 13, 2024 at 2:27 AM
david.fediscience.org.ap.brid.gy
Chasing the source of an assumption, something that lots of #MathOnco #mathbio people do:

https://www.youtube.com/watch?v=bgo7rm5Maqg
We Fell For The Oldest Lie On The Internet
To get started planning a fulfilling career that does a lot of good, go to https://80000hours.org/inanutshell for your free career guide.We are only able to ...
www.youtube.com
December 3, 2024 at 6:16 PM
david.fediscience.org.ap.brid.gy
For those of you here interested in #MathOnco (and maybe #somaticevolution #CancerEvolution) this is an important resource, and since it is a newsletter you can keep up to date with the field whether you are here or twitter (or any other site):

https://thisweekmathonco.substack.com/
November 17, 2024 at 6:30 PM
david.fediscience.org.ap.brid.gy
You could also follow news and announcements about #MathOnco from @mathonco but I have also made our #threads account accessible to the #fediverse so if you prefer this follow @math.onco
November 14, 2024 at 4:37 PM
kitcgallagher.bsky.social
As featured in the #mathonco newsletter, this inspired an artwork exploring the trade-off between appointment frequency and time to progression (background color). The optimal strategy line separates stable and chaotic outcomes, and we tile this pattern with the highest TTP at each tile's center
When implementing Adaptive Therapy (AT) treatment schedules clinically, patients are monitored (and treatment schedules updated) at discrete time intervals. This leads to a trade-off; more frequent clinical appointments allow greater control of the tumor at a higher average size (leading to longer time to progression, or TTP), but are more costly and logistically challenging to implement. We can derive the optimal threshold size for treatment to be used in an AT protocol, and plot this in white over different time intervals between appointments. This is superimposed over the TTP for all different treatment protocols (given by the coloured background) - super-critical protocols on one side of the optimal line leads to chaotic outcomes while sub-optimal protocols achieve a lower TTP. This pattern is tiled and inverted to create a 'chess board', with the highest TTP at the center of each tile, reflecting the optimal game that clinicians are trying to play against the cancer tumor.
April 10, 2025 at 3:46 PM